In addition to OA, GM-CSF has been implicated in the development of inflammatory pain and arthritic pain and disease [16–19], and blockade of GM-CSF and its receptor are currently showing promise in rheumatoid arthritis (RA) trials [15]. The gene discussed is CSF2; the disease is rheumatoid arthritis.